FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091952 [Registered on: 29/07/2025] Trial Registered Prospectively
Last Modified On: 24/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparing two muscle relaxants, Cis-atracurium and Atracurium, to check which provides better conditions for inserting a breathing tube and keeps childrens vital signs more stable during surgery 
Scientific Title of Study   A comparative study between Cis-atracurium and Atracurium for assessment of intubating conditions and hemodynamic stability in pediatric patients undergoing surgery: A randomised double blind study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Abhishek Hansdak 
Designation  Junior Resident 
Affiliation  Rajendra Institute of Medical Sciences 
Address  Department of Anesthesiology, Rajendra Institute of Medical Sciences, Ranchi

Ranchi
JHARKHAND
834009
India 
Phone  9572764664  
Fax    
Email  abhishekhansdak001@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Praveen Kumar Tiwari 
Designation  Additional Professor 
Affiliation  Rajendra Institute of Medical Sciences 
Address  Department of Anesthesiology, Rajendra Institute of Medical Sciences, Bariatu

Ranchi
JHARKHAND
834009
India 
Phone  9661883797  
Fax    
Email  drpkt80@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Mukesh Kumar 
Designation  Assistant Professor 
Affiliation  Rajendra Institute of Medical Sciences 
Address  Department of Anesthesiology, Rajendra Institute of Medical Sciences, Bariatu

Ranchi
JHARKHAND
834009
India 
Phone  7004993204  
Fax    
Email  mukeshgmch@gmail.com  
 
Source of Monetary or Material Support  
Department of Anesthesiology,Rajendra Institute of Medical Sciences,Bariatu,Ranchi, Jharkhand,India Pin code 834009 
 
Primary Sponsor  
Name  Rajendra Institute of Medical Sciences 
Address  Department of Anesthesiology, Rajendra Institute of Medical Sciences, Bariatu, Ranchi, Jharkhand 834009 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Abhishek Hansdak  Rajendra Institute of Medical Sciences.  Department of Anesthesiology, Pediatric Surgery Operation Theatre, RIMS, Bariatu, Ranchi, Jharkhand, India Pin 834009
Ranchi
JHARKHAND 
9572764664

abhishekhansdak001@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Endotracheal intubation using Atracurium   Patient of age 3 to 12 years posted for surgery requiring general anesthesia will be given premedication intravenously with inj. midazolam 0.03mg/kg and inj. glycopyrrolate 0.004mg/kg. Pre-oxygenation will be done with 100% oxygen for 3 minutes. Intravenous general anesthesia will be induced with inj. fentanyl 1.5-2mcg/kg and inj. propofol 2mg/kg. After adequate induction, inj. atracurium will be given at a dose of 0.5mg/kg following which bag and mask ventilation will done for 3 minutes. Under direct laryngoscopy patient will be intubated with appropriate size endotracheal tube and intubating conditions and hemodynamics will be assessed. Expected duration of this intervention will be around 8-10 minutes. Inj atracurium will be repeated intravenously every 25 min at the dose of 0.1mg/kg till the end of surgery.  
Intervention  Endotracheal intubation using Cis-atracurium  Patient of age 3 to 12 years posted for surgery requiring general anesthesia will be given premedication intravenous with inj. midazolam 0.03mg/kg and inj. glycopyrrolate 0.004mg/kg. Pre-oxygenation will be done with 100% oxygen for 3 minutes. Intravenous general anesthesia will be induced with inj. fentanyl 1.5-2mcg/kg and inj. propofol 2mg/kg. After adequate induction inj. cis-atracurium will be given at a dose of 0.2mg/kg following which bag and mask ventilation will be done for 3 minutes. Under direct laryngoscopy patient will be intubated with appropriate size endotracheal tube and intubating conditions and hemodynamics will be assessed. Expected duration of this intervention will be around 8-10 minutes. Inj cis atracurium will be repeated intravenously every 25 min at dose of 0.05mg/kg till the end of surgery. 
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  a Patient’s guardian consent
b Age group 3 to 12 years
c ASA grade 1 and 2
d Patient posted for surgery requiring general anaesthesia and endotracheal intubation
e Expected duration of surgery should be less than 90 minutes 
 
ExclusionCriteria 
Details  a ASA grade 3 and 4
b Anticipated difficult airway
c Comorbid conditions
d Upper and lower respiratory tract infection
e Known history of allergy to any of the study drug 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare effectiveness of Cis-atracurium and Atracurium at dose of 0.2mg/kg and 0.5mg/kg respectively with regards to intubating conditions. Intubating conditions will be assessed using Cooper et al scoring system.  3minutes after injection of muscle relaxant, laryngoscopy will be performed.
At the time of laryngoscopy, and just after intubation, intubating conditions will be assessed using Cooper et al scoring system. 
 
Secondary Outcome  
Outcome  TimePoints 
To assess hemodynamic stability. Systolic Blood pressure, Diastolic blood pressure, Mean Arterial Pressure, Heart rate will be monitored at given time points.  1. baseline parameters before induction
2. 3minutes after preoxygenation with 100 percent oxygen & Intravenous injection of Inj.Propofol.
3. 3minutes after injection of muscle relaxant but before intubation.
4. Immediately after intubation
5. After endotracheal intubation hemodynamic parameters will be assessed at 5minutes, 10minutes, 15minutes, 20minutes, 25minutes, 30minutes 45minutes, 60minutes, 75minutes, 90minutes intraoperatively 
 
Target Sample Size   Total Sample Size="92"
Sample Size from India="92" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   06/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Muscle relaxant is crucial component of general anesthesia which facilitates laryngoscopy and endotracheal intubation, prevents voluntary and reflex movements preventing vocal cord damage. Cis-atracurium and Atracurium are Non depolarising muscle relaxant. Cis-atracurium is 4 times more potent than Atracurium with their ED95 being 0.05mg/kg and 0.23mg/kg respectively. The study is to compare the effectiveness of Cis-atracurium and Atracurium at dose of 4ED95 and 2ED95 which is 0.2mg/kg and 0.5mg/kg respectively with regards to intubating conditions and hemodynamic stability. 
Close